Internal Medicine, Pulmonary Disease · San Diego, CA
NPI
1023436417
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (800) 926-8273
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,528 services
Medicare patients, 2024
524
Average age 71
Drug cost, 2024
$2.7M
1,653 prescriptions
Company payments, 2025
$194
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jisha K Joshua was code 99215 (office e&m - established), 310 times for 128 patients. In total Jisha K Joshua billed 1,528 services in 35 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 310 | 128 | $142.14 | $44K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 292 | 135 | $13.31 | $3,885 |
| 94010 Pulmonary Function Testing | Facility | 206 | 186 | $6.54 | $1,346 |
| 94010 Pulmonary Function Testing | Office | 184 | 145 | $24.02 | $4,420 |
| 94729 Pulmonary Function Testing | Facility | 132 | 127 | $7.11 | $939 |
| 94726 Pulmonary Function Testing | Facility | 100 | 98 | $9.61 | $961 |
| 99233 Hospital E&M - Subsequent | Facility | 79 | 40 | $95.97 | $7,582 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 41 | 28 | $26.03 | $1,067 |
| 99223 Hospital E&M - Initial | Facility | 32 | 30 | $136.13 | $4,356 |
| 99421 Office/Outpatient Services | Office | 18 | 16 | $11.88 | $214 |
| 94060 Pulmonary Function Testing | Facility | 18 | 18 | $8.22 | $148 |
| 94618 Pulmonary Function Testing | Facility | 13 | 13 | $17.84 | $232 |
| 99214 Office E&M - Established | Office | 12 | 11 | $108.64 | $1,304 |
| 99205 Office E&M - New | Office | 11 | 11 | $185.54 | $2,041 |
By year: 2022 $67K for 1,693 services; 2023 $75K for 879 services; 2024 $78K for 1,528 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jisha K Joshua prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 143 prescriptions and refills. In total Jisha K Joshua wrote 1,653 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 143 | 147 | 18 | $1.8M |
| Prednisone Generic | 141 | 234 | 43 | $855 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 122 | 127 | 38 | $3,161 |
| Pirfenidone Generic | 113 | 113 | 17 | $346K |
| Fluticasone Propionate Generic | 72 | 116 | 37 | $588 |
| Spiriva Respimat Tiotropium Bromide | 68 | 80 | 21 | $41K |
| Montelukast Sodium Generic | 61 | 116 | 15 | $451 |
| Mycophenolate Mofetil Generic | 60 | 106 | 16 | $7,448 |
| Omeprazole Generic | 56 | 95 | Under 11 | $251 |
| Furosemide Generic | 55 | 104 | 18 | $265 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 45 | 54 | 11 | $9,911 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 40 | 56 | Under 11 | $34K |
| Breyna Budesonide/Formoterol Fumarate | 40 | 44 | 15 | $8,297 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 36 | 38 | Under 11 | $18K |
| Symbicort Budesonide/Formoterol Fumarate | 35 | 39 | 14 | $8,426 |
Brand drugs: - claims; generic drugs: 896 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jisha K Joshua $194 ($194 in general payments such as food, travel and fees) from 1 company. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $194.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $194 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.